Cargando…

Atypical Antipsychotics in the Treatment of Depressive and Psychotic Symptoms in Patients with Chronic Schizophrenia: A Naturalistic Study

Objectives. The aim of this naturalistic study was to investigate whether treatment with clozapine and other atypical antipsychotics for at least 2 years was associated with a reduction in psychotic and depressive symptoms and an improvement in chronic schizophrenia patients' awareness of their...

Descripción completa

Detalles Bibliográficos
Autores principales:	Innamorati, Marco, Baratta, Stefano, Di Vittorio, Cristina, Lester, David, Girardi, Paolo, Pompili, Maurizio, Amore, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563169/ https://www.ncbi.nlm.nih.gov/pubmed/23401771 http://dx.doi.org/10.1155/2013/423205

Ejemplares similares

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview
por: Pompili, Maurizio, et al.
Publicado: (2016)

Partial Androgen Deficiency, Depression, and Testosterone Supplementation in Aging Men
por: Amore, Mario, et al.
Publicado: (2012)

Incomplete oedipism and chronic suicidality in psychotic depression with paranoid delusions related to eyes
por: Pompili, Maurizio, et al.
Publicado: (2006)

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2006)

Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2008)

Atypical antipsychotics, dystonia, and psychotic depression: old solutions for new problems
por: Gazzellone, Matthew J., et al.
Publicado: (2022)

New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
por: Orzelska-Górka, Jolanta, et al.
Publicado: (2022)

Glycosides, Depression and Suicidal Behaviour: The Role of Glycoside-Linked Proteins
por: Serafini, Gianluca, et al.
Publicado: (2011)

The Association between Cannabis Use, Mental Illness, and Suicidal Behavior: What is the Role of Hopelessness?
por: Serafini, Gianluca, et al.
Publicado: (2013)

Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis
por: Belvederi Murri, Martino, et al.
Publicado: (2015)

Schizophrenia, Depressive Symptoms, and Antipsychotic Drug Treatment
por: Reynolds, Gavin P, et al.
Publicado: (2021)

Schizophrenia risk gene CAV1 is both pro-psychotic and required for atypical antipsychotic drug actions in vivo
por: Allen, J A, et al.
Publicado: (2011)

Association of Typical versus Atypical Antipsychotics with Symptoms and Quality of Life in Schizophrenia
por: Fujimaki, Koichiro, et al.
Publicado: (2012)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Psychometric properties of the stagnation scale in medication overuse headache patients
por: Innamorati, Marco, et al.
Publicado: (2015)

Bereavement after the suicide of a significant other
por: Pompili, Maurizio, et al.
Publicado: (2013)

Exploring risk factors for re-hospitalization in a psychiatric inpatient setting: a retrospective naturalistic study
por: Berardelli, Isabella, et al.
Publicado: (2022)

Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2008)

Do antipsychotics limit disability in schizophrenia? A naturalistic comparative study in the community
por: Thirthalli, Jagadisha, et al.
Publicado: (2010)

Switching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study
por: Cascino, Giammarco, et al.
Publicado: (2022)

Swithching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study
por: Ceres, R., et al.
Publicado: (2023)

Effects of zinc sulfate on schizophrenia symptoms in patients undergoing atypical antipsychotic pharmacotherapy
por: Behrouzian, Forouzan, et al.
Publicado: (2022)

Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka, Michal, et al.
Publicado: (2015)

Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?
por: Pompili, Maurizio, et al.
Publicado: (2008)

Short-Term Psychodynamic Psychotherapy in Patients with “Male Depression” Syndrome, Hopelessness, and Suicide Risk: A Pilot Study
por: Angeletti, Gloria, et al.
Publicado: (2013)

PS78. Naturalistic, retrospective comparison between antidepressant therapy and atypical antipsychotic augmentation therapy for patients with major depressive disorder
por: Cho, Se Hoon, et al.
Publicado: (2016)

White matter hyperintensities and self-reported depression in a sample of patients with chronic headache
por: Serafini, Gianluca, et al.
Publicado: (2012)

Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study
por: Corigliano, Valentina, et al.
Publicado: (2018)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
por: Jeon, Sang Won, et al.
Publicado: (2017)

Severity in schizophrenia patients receiving atypical antipsychotic medications
por: Alam Fatmi1j, Syed Meraj, et al.
Publicado: (2022)

The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder
por: Pompili, Maurizio, et al.
Publicado: (2011)

Antidepressants and Suicide Risk: A Comprehensive Overview
por: Pompili, Maurizio, et al.
Publicado: (2010)

Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations
por: Rossi, Giuseppe, et al.
Publicado: (2012)

Speech-on-speech masking and psychotic symptoms in schizophrenia
por: Wu, Chao, et al.
Publicado: (2018)

Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia
por: Lee, Philip E, et al.
Publicado: (2006)

Understanding Suicidal Behavior: The Contribution of Recent Resting-State fMRI Techniques
por: Serafini, Gianluca, et al.
Publicado: (2016)

Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan
por: Ye, Wenyu, et al.
Publicado: (2012)

Adding antidepressants to antipsychotics for treatment of subsyndromal depressive symptoms in schizophrenia: Impact on positive and negative symptoms
por: Vahia, Ipsit V., et al.
Publicado: (2013)

Lorazepam-Resistant Catatonia in an Antipsychotic-Naïve 24-Year-Old with Psychotic Symptoms
por: Lucchelli, Juan Pablo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9t1ce0uu3vmn2840cp9ed0gu22